Eli Lilly’s oral GLP-1 shows greater efficacy than semaglutide, eyes approval by year-end
Eli Lilly's new oral pill, orforglipron, shows promising results. Trials reveal it is more effective than existing oral treatments. The drug helps in weight loss and blood sugar control. Analysts predict a quick FDA review. Orforglipron could be a game-changer in obesity treatment. It may offer a more accessible and affordable option. The company is expanding production in the USA.
Eli Lilly's new oral pill, orforglipron, shows promising results. Trials reveal it is more effective than existing oral treatments. The drug helps in weight loss and blood sugar control. Analysts predict a quick FDA review. Orforglipron could be a game-changer in obesity treatment. It may offer a more accessible and affordable option. The company is expanding production in the USA.
